Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesEarnSquareMore
Analysis: LAB whales dumped 18.5 million tokens in two days, causing the price to halve

Analysis: LAB whales dumped 18.5 million tokens in two days, causing the price to halve

金色财经金色财经2026/07/12 01:44
Show original
Jinse Finance reported that, on July 12, according to EmberCN monitoring, the LAB whale continued to transfer 10.5 million LAB (approximately $9.15 million) to Aster last night. Over the past 11 hours, LAB fell another 37% to $0.56. Within two days, a total of 18.5 million LAB (around $18.69 million) was transferred, with the price dropping from $1.2 to $0.56, a decrease of 53%. After 8 million LAB (about $9.54 million) was transferred the night before, LAB dropped from $1.2 to $0.89, a fall of 26%. The continued transfers last night led to a further 37% price decline.
0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

U.S. Stocks Movement | Storage Chip Concept Stocks Rise Across the Board, SNDK (SanDisk) Up 6%

On Monday, storage chip concept stocks generally rose, with SanDisk (SNDK.US) up by 6%.

智通财经2026/08/17 13:51
U.S. Stocks Movement | Storage Chip Concept Stocks Rise Across the Board, SNDK (SanDisk) Up 6%

AstraZeneca (AZN.US) / Daiichi Sankyo ADC first-line lung cancer phase III study succeeds

On August 17, AstraZeneca (AZN.US) and Daiichi Sankyo jointly announced that the Phase III DESTINY-Lung04 study of Enhertu (trastuzumab deruxtecan) as a monotherapy for first-line treatment of non-small cell lung cancer (NSCLC) has achieved highly positive results.

智通财经2026/08/17 12:56
AstraZeneca (AZN.US) / Daiichi Sankyo ADC first-line lung cancer phase III study succeeds